This article is more than 5 years old. Information may no longer be current.

Second Sight reports $6.7 million quarterly net loss

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Second Sight Medical Products reported a net loss of $6.7 million, or $0.12 per share, in the third quarter of 2017 compared with a net loss of $8.5 million, or $0.20 per share, in the same quarter of last year, according to a press release.

Total revenue increased from $1.2 million in 2016’s third quarter to $1.6 million in 2017’s third quarter, which was attributed to a higher revenue per Argus II implant due to the higher CMS reimbursement rate.

Total operating expenses for the quarter rose from $7.1 million to $7.4 million due to higher personnel and consulting costs.